Related Experiment Video

Updated: Jun 1, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Therapeutic targeting of apoptotic pathways: novel aspects in pancreatic cancer

A Neesse1, T M Gress, P Michl

  • 1Division of Gastroenterology, Endocrinology and Metabolism, Philipps University Marburg, Baldinger Strasse, Marburg, Germany.

Current Pharmaceutical Biotechnology
|May 25, 2011
PubMed

Insights

Pancreatic cancer is highly resistant to apoptosis due to prosurvival proteins. This review explores resistance mechanisms and therapeutic strategies targeting apoptosis pathways for this aggressive cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Pancreatic cancer exhibits extreme aggressiveness with a dismal 5-year survival rate below 5%.
  • A key characteristic is profound resistance to apoptosis, driven by elevated prosurvival proteins in both extrinsic and intrinsic cell death pathways.

Purpose of the Study:

  • To review current knowledge on apoptotic pathways in pancreatic cancer.
  • To elucidate mechanisms of apoptosis resistance, including signaling pathways and epigenetic factors.
  • To discuss therapeutic strategies targeting apoptosis modulation.

Main Methods:

  • Literature review of current research on pancreatic cancer apoptosis.
  • Analysis of alterations in death receptor and mitochondrial pathways.
  • Examination of the roles of NF-kB, Akt signaling, and histone deacetylases (HDACs).

Main Results:

  • Apoptosis resistance in pancreatic cancer involves complex alterations in cell death signaling.
  • NF-kB, Akt signaling, and HDACs contribute significantly to anti-apoptotic effects.
  • Specific inhibitors targeting these pathways show therapeutic potential in preclinical and clinical studies.

Conclusions:

  • Understanding apoptosis resistance mechanisms is crucial for developing effective pancreatic cancer treatments.
  • Targeting prosurvival pathways offers promising therapeutic avenues for pancreatic cancer.
  • Further investigation into apoptosis modulation is warranted for improved patient outcomes.

More Related Videos

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...